Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin.
Ballı FN, Ekinci PB, Kurtaran M, Kara E, Dizman GT, Sönmezer MÇ, Hayran M, Demirkan K, Metan G. Ballı FN, et al. Among authors: dizman gt. Int J Antimicrob Agents. 2024 Feb;63(2):107035. doi: 10.1016/j.ijantimicag.2023.107035. Epub 2023 Nov 17. Int J Antimicrob Agents. 2024. PMID: 37979889
Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey.
Sonmezer MC, Dizman GT, Erul E, Sahin TK, Saricaoglu T, Alp A, Tanriover MD, Uzun O, Unal S, Akova M. Sonmezer MC, et al. Among authors: dizman gt. Vaccines (Basel). 2022 Jul 18;10(7):1140. doi: 10.3390/vaccines10071140. Vaccines (Basel). 2022. PMID: 35891304 Free PMC article.
Sensitivity Affected by Disease Severity and Serum Sampling Time: a Performance Evaluation of Six SARS-CoV-2 Antibody Immunoassays.
Şener B, Kırbaş E, Sancak B, Gözalan A, Evren E, Karahan ZC, Zeytinoğlu A, Dinç B, Alp A, Dizman GT, Metan G, Birengel S, Gülten E, Taşbakan M, Ayhan M. Şener B, et al. Among authors: dizman gt. Jpn J Infect Dis. 2022 Jul 22;75(4):388-394. doi: 10.7883/yoken.JJID.2021.636. Epub 2022 Mar 31. Jpn J Infect Dis. 2022. PMID: 35354702 Free article.
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
Mert A, Vahaboğlu H, Arslan F, Batirel A, Saraçoğlu KT, Bastug A, Çağatay A, Irmak İ, Dizman GT, Ertenli İ, Altunal LN, Sengel BE, Bayram M, Omma A, Amikishiyev S, Aypak A, Bes C, Bolukçu S, Içten S, Topeli A, Bektaş M, Arslan BY, Öztürk S, Çomoğlu Ş, Aydin S, Küçükşahin O, Içaçan OC, Ince B, Aghamuradov S, Mutlu MY, Şimşek F, Emre S, Ustun C, Ergen P, Aydin Ö, Koç MM, Sevindik ÖG, Odabaşı Z, Korten V, Bodur H, Güner R, Ünal S, Kocak M, Gül A. Mert A, et al. Among authors: dizman gt. Rheumatol Int. 2022 Mar;42(3):457-467. doi: 10.1007/s00296-021-04965-6. Epub 2021 Sep 13. Rheumatol Int. 2022. PMID: 34515808 Free PMC article.
Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study.
UyaroĞlu OA, BaŞaran NÇ, ÖziŞik L, Dİzman GT, EroĞlu İ, Şahİn TK, TaŞ Z, İnkaya AÇ, TanriÖver MD, Metan G, GÜven GS, Ünal S. UyaroĞlu OA, et al. Among authors: dizman gt. Int J Qual Health Care. 2021 Feb 20;33(1):mzaa144. doi: 10.1093/intqhc/mzaa144. Int J Qual Health Care. 2021. PMID: 33104780 Free PMC article.